Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5401
Cartesian Therapeutics
RNAC
$260M
| $105K | ﹤0.01% |
225
+181
| +411% | +$72.7K |
|
|
TGNA
5402
CALL
DELISTED
TEGNA Inc
TGNA
| $105K | ﹤0.01% |
8,800
+7,700
| +700% | +$87.4K |
|
|
SRGA
5403
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $105K | ﹤0.01% |
775
+635
| +454% | +$87.5K |
|
|
SFLY
5404
CALL
DELISTED
Shutterfly, Inc.
SFLY
| $105K | ﹤0.01% |
1,600
+1,500
| +1,500% | +$119K |
|
|
CORI
5405
DELISTED
Corium International, Inc.
CORI
| $105K | ﹤0.01% |
11,012
+5,768
| +110% | +$49.7K |
|
5406
PUT
Becton Dickinson
BDX
$49.4B
| $104K | ﹤0.01% |
410
-146,063
| -100% | -$36M |
|
5407
PUT
Bruker
BRKR
$8.69B
| $104K | ﹤0.01% |
+3,100
| New | +$102K |
|
5408
Clarus
CLAR
$146M
| $104K | ﹤0.01% |
9,395
+7,285
| +345% | +$70K |
|
|
KNDI
5409
PUT
Kandi Technologies Group
KNDI
$63.2M
| $104K | ﹤0.01% |
21,400
+14,000
| +189% | +$59.6K |
|
5410
NWPX Infrastructure Inc
NWPX
$1.08B
| $104K | ﹤0.01% |
5,221
+4,143
| +384% | +$78.4K |
|
5411
PUT
Teradyne
TER
$59.3B
| $104K | ﹤0.01% |
2,800
-1,900
| -40% | -$76.5K |
|
5412
PUT
Texas Roadhouse
TXRH
$13.8B
| $104K | ﹤0.01% |
1,500
-500
| -25% | -$33.9K |
|
5413
Willdan Group
WLDN
$1.28B
| $104K | ﹤0.01% |
3,062
+2,487
| +433% | +$77.6K |
|
|
ABB
5414
PUT
DELISTED
ABB Ltd
ABB
| $104K | ﹤0.01% |
4,400
+4,100
| +1,367% | +$94K |
|
|
ZSAN
5415
DELISTED
Zosano Pharma Corporation
ZSAN
| $104K | ﹤0.01% |
724
-819
| -53% | -$120K |
|
|
SEP
5416
PUT
DELISTED
Spectra Engy Parters Lp
SEP
| $104K | ﹤0.01% |
2,900
-4,300
| -60% | -$159K |
|
5417
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $103K | ﹤0.01% |
3,749
+2,986
| +391% | +$77.7K |
|
5418
PUT
Popular Inc
BPOP
$11.2B
| $103K | ﹤0.01% |
2,000
-31,500
| -94% | -$1.57M |
|
5419
PUT
Celanese
CE
$4.92B
| $103K | ﹤0.01% |
900
-500
| -36% | -$57.3K |
|
5420
CALL
Jefferies Financial Group
JEF
$12.7B
| $103K | ﹤0.01% |
5,251
-3,351
| -39% | -$69.9K |
|
5421
CALL
Plains GP Holdings
PAGP
$4.97B
| $103K | ﹤0.01% |
4,200
| – | – |
|
5422
Uranium Energy
UEC
$5.67B
| $103K | ﹤0.01% |
60,166
+48,066
| +397% | +$79.9K |
|
5423
Vuzix
VUZI
$220M
| $103K | ﹤0.01% |
15,775
+13,991
| +784% | +$94K |
|
|
CNR
5424
CALL
Core Natural Resources Inc
CNR
$4.65B
| $103K | ﹤0.01% |
2,532
-1,800
| -42% | -$75.7K |
|
|
LBC
5425
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $103K | ﹤0.01% |
9,566
+8,527
| +821% | +$96K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.